tiprankstipranks
Kane Biotech Inc (TSE:KNE)
:KNE
Canadian Market

Kane Biotech (KNE) Income Statement

Compare
1 Followers

Kane Biotech Income Statement

Last quarter (Q3 2024), Kane Biotech's total revenue was C$1.28M, an increase of 78.69% from the same quarter last year. In Q3, Kane Biotech's net income was C$-605.81K. See Kane Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
C$ 148.98KC$ 2.67MC$ 1.61MC$ 1.34MC$ 1.69M
Gross Profit
C$ 109.47KC$ 1.41MC$ 568.44KC$ 526.86KC$ 609.91K
Operating Expenses
C$ 3.47MC$ 4.78MC$ 5.45MC$ 4.75MC$ 4.20M
Depreciation and Amortization
C$ 116.05KC$ 257.68KC$ 187.97KC$ 78.11KC$ 54.42K
EBITDA
C$ -3.23MC$ -2.95MC$ -4.25MC$ -3.65MC$ -764.08K
Operating Income
C$ -3.36MC$ -3.36MC$ -4.88MC$ -4.22MC$ -3.59M
Other Income/Expenses
C$ -1.20MC$ -564.03KC$ 33.65KC$ 378.40KC$ 2.63M
Pretax Income
C$ -4.56MC$ -3.82MC$ -4.85MC$ -3.85MC$ -960.18K
Net Income
C$ -5.03MC$ -3.89MC$ -4.60MC$ -3.72MC$ -960.18K
Per Share Metrics
C$ ―C$ ―C$ ―C$ ―C$ ―
Basic EPS
C$ -0.04C$ -0.03C$ -0.04C$ -0.03C$ -0.01
Diluted EPS
C$ -0.04C$ -0.03C$ -0.04C$ -0.03C$ -0.01
Weighted Average Shares Outstanding
140.26M 120.70M 112.60M 107.55M 82.30M
Weighted Average Shares Outstanding (Diluted)
127.12M 120.70M 112.60M 107.55M 82.30M
Currency in CAD

Kane Biotech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis